Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SHE:002566)

SHE:002566 Revenue

Jilin Jian Yisheng Pharmaceutical had revenue of 178.61M CNY in the quarter ending March 31, 2026, with 12.24% growth. This brings the company's revenue in the last twelve months to 659.66M, up 5.17% year-over-year. In the year 2025, Jilin Jian Yisheng Pharmaceutical had annual revenue of 640.17M, down -4.23%.

• Revenue (ttm): 659.66M
• Revenue Growth: +5.17%
• P/S Ratio: 3.53
• Revenue / Employee: 398.34K
• Employees: 1,656
• Market Cap: 2.33B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	640.17M	-28.30M	-4.23%
Dec 31, 2024	668.47M	-185.20M	-21.69%
Dec 31, 2023	853.66M	23.62M	2.85%
Jan 1, 2023	830.04M	-47.89M	-5.45%
Jan 1, 2022	877.93M	35.34M	4.19%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 29, 2026

Data Sources Report a data error